CL2007003817A1 - THERAPEUTIC AGENT FOR INFLAMMATORY MYOPATHY, UNDERSTANDING AN INTERLEUCINE-6 ANTAGONIST (IL-6). - Google Patents

THERAPEUTIC AGENT FOR INFLAMMATORY MYOPATHY, UNDERSTANDING AN INTERLEUCINE-6 ANTAGONIST (IL-6).

Info

Publication number
CL2007003817A1
CL2007003817A1 CL200703817A CL2007003817A CL2007003817A1 CL 2007003817 A1 CL2007003817 A1 CL 2007003817A1 CL 200703817 A CL200703817 A CL 200703817A CL 2007003817 A CL2007003817 A CL 2007003817A CL 2007003817 A1 CL2007003817 A1 CL 2007003817A1
Authority
CL
Chile
Prior art keywords
interleucine
antagonist
understanding
therapeutic agent
inflammatory myopathy
Prior art date
Application number
CL200703817A
Other languages
Spanish (es)
Inventor
Kohsaka Nobuyuki Miyas Hitoshi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39562504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003817(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CL2007003817A1 publication Critical patent/CL2007003817A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CL200703817A 2006-12-27 2007-12-26 THERAPEUTIC AGENT FOR INFLAMMATORY MYOPATHY, UNDERSTANDING AN INTERLEUCINE-6 ANTAGONIST (IL-6). CL2007003817A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006351695A JP2010095445A (en) 2006-12-27 2006-12-27 Therapeutic agent for inflammatory myopathy containing il-6 antagonist as active ingredient

Publications (1)

Publication Number Publication Date
CL2007003817A1 true CL2007003817A1 (en) 2008-06-27

Family

ID=39562504

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703817A CL2007003817A1 (en) 2006-12-27 2007-12-26 THERAPEUTIC AGENT FOR INFLAMMATORY MYOPATHY, UNDERSTANDING AN INTERLEUCINE-6 ANTAGONIST (IL-6).

Country Status (5)

Country Link
JP (1) JP2010095445A (en)
AR (1) AR064538A1 (en)
CL (1) CL2007003817A1 (en)
PE (1) PE20081547A1 (en)
WO (1) WO2008078715A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2382488T3 (en) 1997-03-21 2012-06-08 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for diseases mediated by sensitized t cells comprising an il-6 antagonist as an active ingredient
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
JP4364645B2 (en) 2002-02-14 2009-11-18 中外製薬株式会社 Antibody-containing solution formulation
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
JPWO2005090405A1 (en) 2004-03-24 2008-04-17 中外製薬株式会社 Subtype of humanized antibody against interleukin-6 receptor
PE20091174A1 (en) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd LIQUID FORMULATION WITH HIGH CONCENTRATION OF ANTIBODY CONTENT
CN104928336B (en) 2009-10-26 2020-05-08 弗·哈夫曼-拉罗切有限公司 Method for producing glycosylated immunoglobulins
CN104998254A (en) 2010-11-08 2015-10-28 基因技术公司 Subcutaneously administered anti-IL-6 receptor antibody
CN105378480B (en) 2013-07-04 2018-06-12 豪夫迈·罗氏有限公司 Detect the AF panel immunoassays of anti-drug antibodies in blood serum sample

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3630453B2 (en) * 1994-09-30 2005-03-16 中外製薬株式会社 A therapeutic agent for immature myeloma cells comprising an IL-6 receptor antibody as an active ingredient
CZ296919B6 (en) * 1994-10-07 2006-07-12 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition intended for treating chronic rheumatoid arthritis
ES2382488T3 (en) * 1997-03-21 2012-06-08 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for diseases mediated by sensitized t cells comprising an il-6 antagonist as an active ingredient
ES2299241T3 (en) * 1998-03-17 2008-05-16 Chugai Seiyaku Kabushiki Kaisha PREVENTIVES OR REMEDIES FOR INFLAMMATORY INTESTINAL DISEASES CONTAINING ANTAGONIST ANTIBODIES OF THE IL-6 RECEIVER.
US8440196B1 (en) * 1998-08-24 2013-05-14 Chugai Seiyaku Kabushiki Kaisha Treatment for pancreatitis using IL-6 receptor antagonist antibodies
UA80091C2 (en) * 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
PT2308888T (en) * 2001-11-14 2017-05-03 Janssen Biotech Inc Anti-il-6 antibodies, compositions, methods and uses
AR048210A1 (en) * 2003-12-19 2006-04-12 Chugai Pharmaceutical Co Ltd A PREVENTIVE AGENT FOR VASCULITIS.

Also Published As

Publication number Publication date
WO2008078715A1 (en) 2008-07-03
PE20081547A1 (en) 2009-01-18
AR064538A1 (en) 2009-04-08
JP2010095445A (en) 2010-04-30

Similar Documents

Publication Publication Date Title
CL2007003817A1 (en) THERAPEUTIC AGENT FOR INFLAMMATORY MYOPATHY, UNDERSTANDING AN INTERLEUCINE-6 ANTAGONIST (IL-6).
CL2007001040A1 (en) PROCESS FOR THE PREPARATION OF ANTAGONIST OF THE SUBSTANCE P DERIVED FROM ACIL-AMINO-ALQUILEN-AMIDA.
BRPI0716439A2 (en) flibanserine formulations and method for their manufacture.
BRPI0921242A2 (en) mouthfeel compositions for sensitivity.
BRPI0819218A2 (en) Methods, kits and compositions for administering pharmaceutical compounds
ATE513831T1 (en) PYRIDINÄ3,4-BÜPYRAZINONE
CR10353A (en) NEW COMPOUNDS.
BRPI0912539A2 (en) compound, pharmaceutical composition, method for treating a disease, and use of the compound.
DK1994005T3 (en) Tetrahydronaphthalene derivatives, process for their preparation and use as inflammatory inhibitors
BRPI0920146A2 (en) solubilizing agent for metal ions
BRPI0903914A2 (en) Use of a compound, method for analyzing the efficacy of a sustained release composition, and pharmaceutical composition.
BRPI0814645A2 (en) METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE.
DE112007003101A5 (en) Telemedicine system, especially for chronic diseases
BRPI0719529A2 (en) METHOD FOR PRODUCING SOLID PREPARATION, AND SOLID PREPARATION.
ES1060081Y (en) PART FOR CONSTRUCTION.
BRPI0706249B1 (en) reservoir-roof-floor for buildings.
ES1061647Y (en) ELEVATION DEVICE FOR CONSTRUCTION.
ES1056938Y (en) SET OF INSULATING BOARDS FOR BIDIRECTIONAL FORGING.
ES1060125Y (en) PEANA FOR PARASOLES.
ES1064261Y (en) DEVICE FOR THE CONDUCT OF CONCRETE CHANNELS BY SLIDING COUPLING.
ES1062085Y (en) PROJECTION ARM FOR ROLLING GUIDES OF BLINDS.
BRPI0811781A2 (en) ((FENYL) IMIDAZOLIL) METHYLQUINOLINYL THERAPEUTIC COMPOUNDS.
FR2895038B1 (en) HYDRAULIC SYSTEM.
ES1057726Y (en) PERFECTED POINT FOR CONSTRUCTION.
ES1056758Y (en) DEVICE FOR OROTRAQUEAL INTUBATION.